Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

(2022) Claudia D. Fuchs et al.   Nature Reviews Gastroenterology & Hepatology

The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease

(2022) John P. Thomas et al.   Frontiers in Immunology

A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice

(2022) Liqiong Song et al.   Frontiers in Immunology

Bile Acids: Key Players in Inflammatory Bowel Diseases?

(2022) Aicha Kriaa et al.   Cells

5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism

(2022) Ling Huang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Immunomodulatory functions of FXR

(2022) Stefano Fiorucci et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Bile Acids Activated Receptors in Inflammatory Bowel Disease

(2021) Michele Biagioli et al.   Cells

Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis

(2021) Haoran Ke et al.   Frontiers in Pharmacology

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

(2020) Aonghus Lavelle et al.   Nature Reviews Gastroenterology & Hepatology

Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease

(2020) F. J. Ryan et al.   Nature Communications

Focus on the Role of NLRP3 Inflammasome in Diseases

(2020) Roberta Fusco et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Inflammatory Bowel Disease – Non-biological treatment

(2020) Fernando Magro et al.   PHARMACOLOGICAL RESEARCH

Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis

(2019) Naofumi Yoshida et al.   CIRCULATION

Emerging roles of bile acids in mucosal immunity and inflammation

(2019) Mei Lan Chen et al.   Mucosal Immunology

Probing Clostridium difficile Infection in Complex Human Gut Cellular Models

(2019) Blessing O. Anonye et al.   Frontiers in Microbiology

Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota

(2019) You Jin Jang et al.   Gut Microbes

Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice

(2019) Xiaoyuan Bian et al.   Frontiers in Microbiology

Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review

(2019) Rapat Pittayanon et al.   GASTROENTEROLOGY

Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation

(2018) Zhao-Hua Shen et al.   WORLD JOURNAL OF GASTROENTEROLOGY

A selective gut bacterial bile salt hydrolase alters host metabolism

(2018) Lina Yao et al.   eLife

Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease

(2018) Margaret Delday et al.   INFLAMMATORY BOWEL DISEASES

VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice

(2018) Chun-Sai-Er Wang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis

(2018) Nicole Ranson et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

(2018) Lulu Sun et al.   NATURE MEDICINE

Interactions between gut bacteria and bile in health and disease

(2017) Sarah L. Long et al.   MOLECULAR ASPECTS OF MEDICINE

Chemically induced mouse models of acute and chronic intestinal inflammation

(2017) Stefan Wirtz et al.   Nature Protocols

Gut microbiota and IBD: causation or correlation?

(2017) Josephine Ni et al.   Nature Reviews Gastroenterology & Hepatology

Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

(2017) Wei Jia et al.   Nature Reviews Gastroenterology & Hepatology

Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties

(2016) C. Preston Neff et al.   Cell Host & Microbe

CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database

(2016) Baofeng Jia et al.   NUCLEIC ACIDS RESEARCH

Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis

(2016) Natalia Gomez-Ospina et al.   Nature Communications

A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes

(2015) Austin G. Davis-Richardson et al.   DIABETOLOGIA

Bacterial metabolites directly modulate farnesoid X receptor activity

(2015) Xianqin Zhang et al.   Nutrition & Metabolism

Dysbiosis of Gut Microbiota With Reduced Trimethylamine‐N‐Oxide Level in Patients With Large‐Artery Atherosclerotic Stroke or Transient Ischemic Attack

(2015) Jia Yin et al.   Journal of the American Heart Association

The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention

(2014) Mitchell L Jones et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes

(2014) Alain Labbé et al.   PLoS One

Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes

(2014) Austin G. Davis-Richardson et al.   Frontiers in Microbiology

Species differentiation of Bacteroides dorei from Bacteroides vulgatus and Bacteroides ovatus from Bacteroides xylanisolvens – Back to basics

(2013) Rune M. Pedersen et al.   ANAEROBE

Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist

(2013) Sama I. Sayin et al.   Cell Metabolism

UPARSE: highly accurate OTU sequences from microbial amplicon reads

(2013) Robert C Edgar   NATURE METHODS

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

(2013) Fei Li et al.   Nature Communications

Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?: Figure 1

(2012) Lesley A Ogilvie et al.   GUT

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

(2012) Henri Duboc et al.   GUT

Bile Salt Hydrolase (Bsh) Activity Screening of Lactobacilli: In Vitro Selection of Indigenous Lactobacillus Strains with Potential Bile Salt Hydrolysing and Cholesterol-Lowering Ability

(2012) Rajesh Kumar et al.   Probiotics and Antimicrobial Proteins

FLASH: fast length adjustment of short reads to improve genome assemblies

(2011) T. Magoc et al.   BIOINFORMATICS

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

(2011) R. M. Gadaleta et al.   GUT

Intestinal Bacteroides species associated with coeliac disease

(2010) E. Sanchez et al.   JOURNAL OF CLINICAL PATHOLOGY

QIIME allows analysis of high-throughput community sequencing data

(2010) J Gregory Caporaso et al.   NATURE METHODS

The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity

(2009) P. Vavassori et al.   JOURNAL OF IMMUNOLOGY

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

A microbial symbiosis factor prevents intestinal inflammatory disease

(2008) Sarkis K. Mazmanian et al.   NATURE

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome

(2008) B. V. Jones et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA